Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial | PLOS ONE
Bronchiolitis obliterans - Wikipedia
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. | Semantic Scholar
Flowchart of patient selection. LTx: lung transplantation; BOS:... | Download Scientific Diagram
Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally | Bone Marrow Transplantation
Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation
BOS – Lung Transplant Foundation
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome | European Respiratory Society
Bronchiolitis Obliterans | Concise Medical Knowledge
Frontiers | Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
Survival in Lung Transplant Recipients: What Do We Know About Bronchiolitis Obliterans Syndrome?
Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling. | Semantic Scholar
A review of bronchiolitis obliterans syndrome and therapeutic strategies | Journal of Cardiothoracic Surgery | Full Text
Bronchiolitis Obliterans Syndrome: The Final Frontier for Lung Transplantation - ScienceDirect
Obliterative bronchiolitis | Radiology Reference Article | Radiopaedia.org
Developing a novel inhaled therapeutic for the treatment of bronchiolitis obliterans syndrome - Research Outreach
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation - Neurohr - 2022 - American Journal of Transplantation - Wiley Online Library
Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and Other Late-Onset Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation - ScienceDirect
Bronchiolitis obliterans - Wikipedia
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review | European Respiratory Society
Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation - American Journal of Transplantation
Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and Other Late-Onset Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow ...
Bronchiolitis Obliterans Syndrome | SpringerLink
![PDF] Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6ea05c86a93ce5e6e4bf212ff926772c54b2c48/5-TableII-1.png "PDF] Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. | Semantic Scholar")
PDF] Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. | Semantic Scholar
American Thoracic on Twitter: "Up to half of lung transplant recipients develop bronchiolitis obliterans syndrome within five years of transplantation. Learn more: https://t.co/5D6imdw3fY #ATSLungFact https://t.co/vIZVwxRvFT" / Twitter
